Black Diamond Therapeutics, Inc. Share Price
Equities
BDTX
US09203E1055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 USD | +15.26% | +11.98% | +109.61% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 309M 24.77B |
---|---|---|---|---|---|
Net income 2024 * | -93M -7.44B | Net income 2025 * | -121M -9.69B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.44
x | P/E ratio 2025 * |
-3.29
x | Employees | 54 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.44% |
1 day | +15.26% | ||
1 week | +11.98% | ||
Current month | +16.17% | ||
1 month | +15.72% | ||
3 months | +103.10% | ||
6 months | +213.30% | ||
Current year | +109.61% |
Managers | Title | Age | Since |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 31/12/13 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 08/08/21 |
David Epstein
FOU | Founder | 65 | 31/12/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 31/12/13 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 08/08/21 |
Ali Behbahani
BRD | Director/Board Member | 47 | 30/11/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 5.89 | +15.26% | 567,043 |
25/04/24 | 5.11 | +0.99% | 233,076 |
24/04/24 | 5.06 | +1.00% | 362,011 |
23/04/24 | 5.01 | -0.20% | 356,283 |
22/04/24 | 5.02 | -4.56% | 512,721 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+109.61% | 309M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BDTX Stock